183 related articles for article (PubMed ID: 33707516)
1. Canine mammary cancer tumour behaviour and patient survival time are associated with collagen fibre characteristics.
Garcia APV; Reis LA; Nunes FC; Longford FGJ; Frey JG; de Paula AM; Cassali GD
Sci Rep; 2021 Mar; 11(1):5668. PubMed ID: 33707516
[TBL] [Abstract][Full Text] [Related]
2. Identification of prognostic collagen signatures and potential therapeutic stromal targets in canine mammary gland carcinoma.
Case A; Brisson BK; Durham AC; Rosen S; Monslow J; Buza E; Salah P; Gillem J; Ruthel G; Veluvolu S; Kristiansen V; Puré E; Brown DC; Sørenmo KU; Volk SW
PLoS One; 2017; 12(7):e0180448. PubMed ID: 28683102
[TBL] [Abstract][Full Text] [Related]
3. Impact of Histological Subtype on Survival in Canine Mammary Carcinomas: a Retrospective Analysis of 155 Cases.
Seung BJ; Cho SH; Kim SH; Bae MK; Lim HY; Kwak SW; Sur JH
J Comp Pathol; 2021 Jul; 186():23-30. PubMed ID: 34340801
[TBL] [Abstract][Full Text] [Related]
4. Expression of Tumour Endothelial Marker 8 in Canine Mammary Gland Tumour Cells.
Noguchi S; Araki M; Nakajima K; Koh M; Kokado Y; Kubo Y; Otsuka H; Yasuda A; Yokosuka M; Soeta S
J Comp Pathol; 2019 Nov; 173():30-40. PubMed ID: 31812171
[TBL] [Abstract][Full Text] [Related]
5. Sialyl Lewis x expression in canine malignant mammary tumours: correlation with clinicopathological features and E-Cadherin expression.
Pinho SS; Matos AJ; Lopes C; Marcos NT; Carvalheira J; Reis CA; Gärtner F
BMC Cancer; 2007 Jul; 7():124. PubMed ID: 17617904
[TBL] [Abstract][Full Text] [Related]
6. A comparative study between mixed-type tumours from human salivary and canine mammary glands.
Genelhu MC; Cardoso SV; Gobbi H; Cassali GD
BMC Cancer; 2007 Nov; 7():218. PubMed ID: 18045453
[TBL] [Abstract][Full Text] [Related]
7. Collagen molecular phenotypic switch between non-neoplastic and neoplastic canine mammary tissues.
Terajima M; Taga Y; Brisson BK; Durham AC; Sato K; Uzawa K; Saito T; Hattori S; Sørenmo KU; Yamauchi M; Volk SW
Sci Rep; 2021 Apr; 11(1):8659. PubMed ID: 33883562
[TBL] [Abstract][Full Text] [Related]
8. Association of mast cell density, microvascular density and endothelial area with clinicopathological parameters and prognosis in canine mammary gland carcinomas.
Sakalauskaitė S; Riškevičienė V; Šengaut J; Juodžiukynienė N
Acta Vet Scand; 2022 Jun; 64(1):14. PubMed ID: 35761297
[TBL] [Abstract][Full Text] [Related]
9. Histopathological and immunohistochemical assessment of invasive micropapillary mammary carcinoma in dogs: a retrospective study.
Gamba CO; Dias EJ; Ribeiro LG; Campos LC; Estrela-Lima A; Ferreira E; Cassali GD
Vet J; 2013 May; 196(2):241-6. PubMed ID: 23031308
[TBL] [Abstract][Full Text] [Related]
10. Relationship between Histological Grade and Histopathological Appearance in Canine Mammary Carcinomas.
Tanaka Y; Koyama K; Horiuchi N; Watanabe K; Kobayashi Y
J Comp Pathol; 2020 Aug; 179():59-64. PubMed ID: 32958149
[TBL] [Abstract][Full Text] [Related]
11. Canine mammary gland disease in New Zealand: a review of samples from 797 dogs.
Ariyarathna H; Aberdein D; Thomson N; Gibson I; Munday JS
N Z Vet J; 2022 Mar; 70(2):95-100. PubMed ID: 34756151
[TBL] [Abstract][Full Text] [Related]
12. Tumour-associated macrophages: Relation with progression and invasiveness, and assessment of M1/M2 macrophages in canine mammary tumours.
Monteiro LN; Rodrigues MA; Gomes DA; Salgado BS; Cassali GD
Vet J; 2018 Apr; 234():119-125. PubMed ID: 29680383
[TBL] [Abstract][Full Text] [Related]
13. Alterations in collagen fibre patterns in breast cancer. A premise for tumour invasiveness?
Brabrand A; Kariuki II; Engstrøm MJ; Haugen OA; Dyrnes LA; Åsvold BO; Lilledahl MB; Bofin AM
APMIS; 2015 Jan; 123(1):1-8. PubMed ID: 25131437
[TBL] [Abstract][Full Text] [Related]
14. Collagen density promotes mammary tumor initiation and progression.
Provenzano PP; Inman DR; Eliceiri KW; Knittel JG; Yan L; Rueden CT; White JG; Keely PJ
BMC Med; 2008 Apr; 6():11. PubMed ID: 18442412
[TBL] [Abstract][Full Text] [Related]
15. Low Stromal Mast Cell Density in Canine Mammary Gland Tumours Predicts a Poor Prognosis.
Ariyarathna H; Thomson N; Aberdein D; Munday JS
J Comp Pathol; 2020 Feb; 175():29-38. PubMed ID: 32138840
[TBL] [Abstract][Full Text] [Related]
16. Versican expression in canine carcinomas in benign mixed tumours: is there an association with clinical pathological factors, invasion and overall survival?
Damasceno KA; Bertagnolli AC; Estrela-Lima A; Ribeiro LG; Rabelo BS; Campos CB; Barros AL; Cassali GD
BMC Vet Res; 2012 Oct; 8():195. PubMed ID: 23082892
[TBL] [Abstract][Full Text] [Related]
17. Canine mammary gland tumours; a histological continuum from benign to malignant; clinical and histopathological evidence.
Sorenmo KU; Kristiansen VM; Cofone MA; Shofer FS; Breen AM; Langeland M; Mongil CM; Grondahl AM; Teige J; Goldschmidt MH
Vet Comp Oncol; 2009 Sep; 7(3):162-72. PubMed ID: 19691645
[TBL] [Abstract][Full Text] [Related]
18. Expression of CD44 in canine mammary tumours.
Paltian V; Alldinger S; Baumgärtner W; Wohlsein P
J Comp Pathol; 2009 Nov; 141(4):237-47. PubMed ID: 19592009
[TBL] [Abstract][Full Text] [Related]
19. Heat shock protein expression in canine malignant mammary tumours.
Romanucci M; Marinelli A; Sarli G; Della Salda L
BMC Cancer; 2006 Jun; 6():171. PubMed ID: 16803633
[TBL] [Abstract][Full Text] [Related]
20. Role of body condition score and adiponectin expression in the progression of canine mammary carcinomas.
Tesi M; Millanta F; Poli A; Mazzetti G; Pasquini A; Panzani D; Rota A; Vannozzi I
Vet Med Sci; 2020 Aug; 6(3):265-271. PubMed ID: 32202386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
